Literature DB >> 10149144

Initial in-vivo evaluation of glass-ionomer cements for use as alveolar bone substitutes.

I M Brook1, G T Craig, D J Lamb.   

Abstract

The response of rat femora to implantation of four glass-ionomer (polyalkenoic) cements (GIC) compared to that seen following implantation of densely sintered hydroxyapatite (Ha) ceramic was evaluated for periods up to 12 weeks. Light and transmission electron microscopic analysis of the GIC/bone interface revealed direct bonding of the GIC G338 and Ketac Cem (both based on fluoro-alumino-silicate) glasses to bone, with a mineralized collagen-containing extra-cellular matrix deposited on the surface of the GIC. AquaCem and the fluoride-free GIC based on MP4 glass showed incomplete osseointegration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 10149144     DOI: 10.1016/0267-6605(91)90073-o

Source DB:  PubMed          Journal:  Clin Mater        ISSN: 0267-6605


  5 in total

1.  Detection of mutagenic potential of some glass-ionomer cements through Ames testing.

Authors:  S Stea; M Cervellati; D Cavedagna; L Savarino; E Cenni; A Pizzoferrato; S Stea
Journal:  J Mater Sci Mater Med       Date:  1998-03       Impact factor: 3.896

2.  Dependence of in vitro biocompatibility of ionomeric cements on ion release.

Authors:  A J Devlin; P V Hatton; I M Brook
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

3.  Effects of glass ionomer cements on bone tissue.

Authors:  P Lucksanasombool; W A J Higgs; R J E D Higgs; M V Swain; C R Howlett
Journal:  J Mater Sci Mater Med       Date:  2002-02       Impact factor: 3.896

4.  The influence of poly(acrylic acid) molar mass on the properties of polyalkenoate cements formed from zinc oxide/apatite mixtures.

Authors:  S Kenny; R G Hill; M Towler
Journal:  J Mater Sci Mater Med       Date:  2000-12       Impact factor: 3.896

5.  Fluoride release from model glass ionomer cements.

Authors:  A Guida; R G Hill; M R Towler; S Eramo
Journal:  J Mater Sci Mater Med       Date:  2002-07       Impact factor: 3.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.